Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

30 trials with published results (17%)

Research Maturity

114 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.2%

9 terminated out of 173 trials

Success Rate

92.7%

+6.2% vs benchmark

Late-Stage Pipeline

27%

47 trials in Phase 3/4

Results Transparency

26%

30 of 114 completed with results

Key Signals

30 with results93% success

Data Visualizations

Phase Distribution

139Total
Not Applicable (18)
Early P 1 (1)
P 1 (34)
P 2 (39)
P 3 (31)
P 4 (16)

Trial Status

Completed114
Unknown25
Recruiting13
Terminated9
Withdrawn6
Not Yet Recruiting5

Trial Success Rate

92.7%

Benchmark: 86.5%

Based on 114 completed trials

Clinical Trials (173)

Showing 20 of 20 trials
NCT05537896Phase 2Recruiting

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

NCT06056297Phase 3RecruitingPrimary

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

NCT00967785Phase 1Recruiting

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT06788691Phase 2Recruiting

Luspatercept for Clonal Cytopenias of Uncertain Significance

NCT07396571Not Yet Recruiting

Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae

NCT07434063RecruitingPrimary

Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

NCT07300735Not ApplicableRecruiting

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

NCT07237906CompletedPrimary

Neutropenia With TNF-α Inhibitors

NCT04448301Not ApplicableCompleted

PC001- A Study to Evaluate the Usability of PointCheck

NCT01916057Not ApplicableCompleted

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis

NCT04154488Phase 1CompletedPrimary

A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders

NCT04904614Phase 4Completed

Letermovir Use in Heart Transplant Recipients

NCT07066085Early Phase 1Recruiting

Serial Blood Count Study

NCT07047352Not ApplicableNot Yet Recruiting

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)

NCT07018271Not ApplicableNot Yet Recruiting

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

NCT01660347Not ApplicableWithdrawn

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

NCT04174599Phase 3Completed

Study to Compare the Efficacy and Safety of F-627 and GRAN®

NCT05626530Phase 4Recruiting

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

NCT06537726Recruiting

Breath Analysis for the Detection of Invasive Fungal Infections

NCT06913998Recruiting

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Scroll to load more

Research Network

Activity Timeline